Entheon Biomedical Corp. Acquires Lobo Genetics Inc.
Vancouver, British Columbia–(Newsfile Corp. – July 30, 2021) – Entheon Biomedical Corp. (CNSX:ENBI.CN) (OTCQB:ENTBF) (FSE:1XU1) (” Entheon ” or the ” Company “) is pleased to announce that the Company completed its acquisition of Lobo Genetics Inc. (” Lobo “), a personalized genetics company with a direct-to-consumer platform currently being used in both the psychedelics and cannabis spaces to provide personalized […]
Core One’s Dr. Robert E.W. Hancock to Host Virtual Townhall Webcast and Present on Proprietary Biosynthesized Psilocybin Wednesday, August 4, 2021
Core One Labs Inc. (CNSX:COOL.CN), (OTC:CLABD), (Frankfurt: LD6, WKN: A3CSSU) (“Core One” or the “Company”) is pleased to announce that Dr. Robert E.W. Hancock, the Company’s Chairman, and CEO of its wholly owned subsidiary Vocan Biotechnologies Inc. will be presenting at the Company’s Virtual Town Hall webcast on Wednesday, August 4, 2021 at 1:30 p.m. […]